Bonti Announces Presentation Featuring EB-001A at Masters of Aesthetics Symposium
23.08.2018
Dr. Jean Carruthers to Highlight Key Aesthetic Clinical Study Results for This Novel Neurotoxin with a Unique Clinical Profile.
News
Bonti Announces Successful Completion of Phase 2a Scar Reduction Clinical Study
02.08.2018
SHINE-1 Results Suggest EB-001A May Improve Appearance of Scars.
New data on the tissue regeneration after muscle injury using MRI and DCE-MRI
25.07.2018
Tissue repair is a prolonged process that lasts for at least six months after a severe muscle strain injury
IAG Strengthens Team with New Appointments in the European and North American Offices
16.07.2018
The Company welcoms Dr. Boubakeur Belaroussi as Head of Product, Maartje Meijer as Head of Operations, Frank Cerrone as a lead MRI Technologist and Yeda Ford as a Head of Commercial Operations.
Jason Fontenot, Ph.D., Joins Immusoft as Chief Scientific Officer
10.07.2018
He is an internationally recognized immunologist with expertise in immune cell biology, cell engineering and immune-mediated disease.